Logo
Arrow
LoginConnect Now
Logo
Arrow
Arrow

Finished Dosage Forms - Product List:

Dr. Reddy’s Laboratories is a leading API supplier, with a presence in over 80 countries and a portfolio of 200+ ANDA filings and approved dossiers. Our offering goes beyond APIs and our global customers have access to high-quality dossiers and finished dosage forms.

Search
Therapy Areaarrow
Dosage Formarrow
Dossier Statusarrow
Therapy AreaProduct NameOralInjStrengthDossier StatusConnect
Anti-DiabeticLinagliptinTick5 mgFiledEnvelope
Anti-DiabeticSitagliptin HCL + MetforminTick50 + 500, 50 + 850Under DevelopmentEnvelope
Anti-DiabeticLinagliptin + MetforminTick2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1000 mgFiledEnvelope
Anti-DiabeticSitagliptin HCLTick25, 50, 100 mgFiledEnvelope
Anti-DiabeticSitagliptin PhosphateTick25, 50 and 100 mgFiledEnvelope
Anti-DiabeticSitagliptin Phosphate + MetforminTick50 + 500, 50 + 1000 mgFiledEnvelope
Anti-DiabeticLiraglutideTick6 mg/ml (3 ml)Under DevelopmentEnvelope
Anti-ObesityLiraglutideTick6 mg/ml (3 ml)Under DevelopmentEnvelope
CardiovascularEltrombopagTick12.5, 25, 50 and 75 mgFiledEnvelope
CardiovascularBempedoic acid EzetimibeTick180 mg/10 mgUnder DevelopmentEnvelope
CardiovascularBempedoic acidTick120 mg and 240 mgUnder DevelopmentEnvelope
CardiovascularEdoxabanTick15 mg, 30 mg and 60 mgUnder DevelopmentEnvelope
CardiovascularTafamidis MeglumineTick20 mgUnder DevelopmentEnvelope
CardiovascularApixabanTick2.5 mg and 5 mgFiledEnvelope
CardiovascularDabigatranTick75 mg, 110 mg and 150 mgFiledEnvelope
CardiovascularRivaroxabanTick10, 15 and 20 mgFiledEnvelope
CardiovascularSacubitril/ ValsartanTick24/26, 49/51, 97/103 mgFiledEnvelope
CardiovascularTicagrelorTick60 mg and 90 mgFiledEnvelope
CardiovascularTreprostinilTick1 mg/ml, 2.5 mg/ml, 5 mg/ml and 10 mg/ml (20 ml)FiledEnvelope
CardiovascularFondaparinuxTick2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml and 10 mg/0.8 mlFiledEnvelope
Page 1 of 5

Product Capabilities

1R&D and Manufacturing Capabilities
Toggle
Research and DevelopmentManufacturing FacilitiesNich Product OpportunitiesVertical Integration
4 State-of-the-art R&D centres in India, U.K., U.S., and Netherlands 1200+ research scientists working on various projects11 formulations manufacturing facilitiesPeptides, Prostaglandins, HPAPIs, Innovative drug delivery, Novel dosage forms, Complex InjectablesMore than 60% of our formulations are backward integrated with our In- house API

Our 11 formulations manufacturing facilities that are operated in accordance with cGMP (ICH Q7a) and regularly inspected/audited by international regulatory authorities and customers (USFDA, MHRA, EMA, PMDA, TGA, SAHPRA, ANVISA, Russian MoH, CFDA, COFEPRIS and Health Canada).

2Product Capabilities
Toggle

Dr. Reddy's has an expertise of developing and manufacturing various dosage forms:

Oral SolidsInjectablesNovel Dosage Forms
Tablets, Chewable tablets, OrodispersibleLyophilized product and Liquid solutionEmulsions, Suspensions, Microspheres Liposomes tablets, Capsules, soft gel capsules Pellets a and Nanoparticles
3Service Capabilities
Toggle

Highly experienced and integrated technical team to support from filing-to-launch. Highly experienced technical and global regulatory teams with experience of 350+ Filings and 150+ approvals across B2B markets.

Regulatory servicesTech Transfer supportBio Study design support
Team of regulatory expertsComplete knowledge transferClinical pharmacokinetic team available
Support filing activitiesSupport local manufacturingDesign bio study protocol

Across multiple countries of interest

Meet with our product experts in one-on-one virtual sessions

Our experts will answer your questions, provide advice, and help you understand our products better

Request a Call Backbutton arrow
meet with img
alt
alt

Global Presence

alt
  • altEurope
  • altMexico
  • altArgentina
  • altTurkey
  • altMena
  • altNorth Asia

Re-imagine API sourcing with Dr. Reddy's

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.